Cogent Price To Free Cash Flows Ratio from 2010 to 2024

COGT Stock  USD 7.76  0.08  1.02%   
Cogent Biosciences Price To Free Cash Flows Ratio yearly trend continues to be comparatively stable with very little volatility. Price To Free Cash Flows Ratio will likely drop to -3.14 in 2024. From the period from 2010 to 2024, Cogent Biosciences Price To Free Cash Flows Ratio quarterly data regression had mean square error of  4.12 and mean deviation of  3.46. View All Fundamentals
 
Price To Free Cash Flows Ratio  
First Reported
2010-12-31
Previous Quarter
(2.99)
Current Value
(3.14)
Quarterly Volatility
3.82230049
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Cogent Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cogent Biosciences' main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.7 M, Interest Expense of 4.8 M or Selling General Administrative of 36.1 M, as well as many indicators such as Price To Sales Ratio of 12.32, Dividend Yield of 0.0 or PTB Ratio of 1.23. Cogent financial statements analysis is a perfect complement when working with Cogent Biosciences Valuation or Volatility modules.
  
Check out the analysis of Cogent Biosciences Correlation against competitors.
For more information on how to buy Cogent Stock please use our How to Invest in Cogent Biosciences guide.

Latest Cogent Biosciences' Price To Free Cash Flows Ratio Growth Pattern

Below is the plot of the Price To Free Cash Flows Ratio of Cogent Biosciences over the last few years. It is Cogent Biosciences' Price To Free Cash Flows Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cogent Biosciences' overall financial position and show how it may be relating to other accounts over time.
Price To Free Cash Flows Ratio10 Years Trend
Slightly volatile
   Price To Free Cash Flows Ratio   
       Timeline  

Cogent Price To Free Cash Flows Ratio Regression Statistics

Arithmetic Mean(0.45)
Coefficient Of Variation(847.45)
Mean Deviation3.46
Median(2.77)
Standard Deviation3.82
Sample Variance14.61
Range9.3676
R-Value(0.86)
Mean Square Error4.12
R-Squared0.74
Significance0.000041
Slope(0.73)
Total Sum of Squares204.54

Cogent Price To Free Cash Flows Ratio History

2024 -3.14
2023 -2.99
2022 -5.41
2021 -5.49
2020 -3.47
2019 -0.53
2018 -3.32

About Cogent Biosciences Financial Statements

Cogent Biosciences shareholders use historical fundamental indicators, such as Price To Free Cash Flows Ratio, to determine how well the company is positioned to perform in the future. Although Cogent Biosciences investors may analyze each financial statement separately, they are all interrelated. The changes in Cogent Biosciences' assets and liabilities, for example, are also reflected in the revenues and expenses on on Cogent Biosciences' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Price To Free Cash Flows Ratio(2.99)(3.14)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Cogent Stock Analysis

When running Cogent Biosciences' price analysis, check to measure Cogent Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cogent Biosciences is operating at the current time. Most of Cogent Biosciences' value examination focuses on studying past and present price action to predict the probability of Cogent Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cogent Biosciences' price. Additionally, you may evaluate how the addition of Cogent Biosciences to your portfolios can decrease your overall portfolio volatility.